Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(8/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(8/week)
News
United States
(492/week)
Manufacturing
(332/week)
Energy
(271/week)
Technology
(348/week)
Other Energy
(234/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
National Psoriasis Foundation
Jun 03, 2020
New First-in-Class Phase 3 TREMFYA® (guselkumab) Data Demonstrate Improvement in Psoriatic Arthritis Joint and Skin Symptoms at Week 52
Apr 06, 2020
The Lancet Simultaneously Publishes Two Phase 3 Studies Detailing Comprehensive Efficacy and Safety of TREMFYA® (guselkumab), a First-in-Class IL-23 p19 Subunit Inhibitor, in Psoriatic Arthritis
Nov 13, 2019
Novartis launches PsO at Work with music icon Cyndi Lauper to bring to life the impact psoriasis can have in the workplace
Nov 11, 2019
TREMFYA® (guselkumab), a First-in-Class IL-23 p19 Subunit Inhibitor, Meets Primary Endpoints of Superior ACR20 Responses versus Placebo at Week 24 in Phase 3 Psoriatic Arthritis Studies
Oct 12, 2019
Lilly Presents Positive Results for Taltz® (ixekizumab) in Pediatric Patients with Moderate to Severe Plaque Psoriasis at the 28th Annual European Academy of Dermatology and Venereology (EADV) Congress
Sep 23, 2019
International Council Of Dermatologists Introduces New Method Of Determining Psoriasis Severity
Jun 14, 2019
Sun Pharma Announces Late-Breaking Phase 2 Data Showing Potential of ILUMYA(TM) (tildrakizumab-asmn) to Improve Joint and Skin Symptoms of Psoriatic Arthritis
Jun 11, 2019
Lilly to Present 5-Year Sustained Efficacy and Safety Results for Taltz® (ixekizumab) in Patients with Plaque Psoriasis at the World Congress of Dermatology
Apr 16, 2019
Patient Advocates Applaud Filing of the 'Safe Step Act' in U.S. House of Representatives
Mar 26, 2019
AbbVie Announces First Regulatory Approval of SKYRIZI(TM) (risankizumab) for the Treatment of Plaque Psoriasis, Generalized Pustular Psoriasis and Erythrodermic Psoriasis and Psoriatic Arthritis in Japan
Feb 28, 2019
Ortho Dermatologics To Present New Analyses At The American Academy Of Dermatology Annual Meeting
Feb 27, 2019
Sun Pharmaceutical Industries Inc. Announces Plans to Present 19 Data Abstracts on ILUMYA(TM) for Moderate-to-Severe Plaque Psoriasis at American Academy of Dermatology 2019 Annual Meeting
Dec 12, 2018
New Phase 3 data demonstrate superiority of TREMFYA® (guselkumab) vs Cosentyx® (secukinumab) in delivering PASI 90 responses in the treatment of moderate to severe plaque psoriasis at week 48
Oct 08, 2018
Bausch Health's BRYHALI(TM)(halobetasol propionate) Lotion, 0.01%, Receives Tentative FDA Approval For Plaque Psoriasis In Adults
Oct 02, 2018
Ortho Dermatologics Announces Publication Of Pivotal Phase 3 Efficacy And Safety Data On Bryhali(TM)* (Halobetasol Propionate) Lotion, 0.01% In The Journal Of Drugs In Dermatology
Sep 12, 2018
ECHT-EVAL 2018 - The German Project Implementing the WHO 'Global Report on Psoriasis'
Sep 10, 2018
Lilly Announces Initiation of IXORA-R Head-to-Head Trial Comparing Taltz® and Tremfya® in Patients with Moderate-to-Severe Plaque Psoriasis
Aug 13, 2018
Escalier Doses First Patient with ESR-114 and Announces Clinical Advisory Board
Jul 24, 2018
Unlike Beauty, Psoriasis More Than Skin Deep
Jun 19, 2018
Novartis receives FDA approval for inclusion of new evidence that Cosentyx® inhibits progression of joint structural damage in psoriatic arthritis
Page 1
››
Latest News
Apr 18, 2024
Montrose Environmental Group Announces Pricing of Public Offering of Shares
Apr 18, 2024
SkyWater Technology to Announce First Quarter Financial Results on May 8th, 2024
Apr 18, 2024
CF Industries and JERA Announce Joint Development Agreement to Develop Greenfield Low-Carbon Ammonia...
Apr 18, 2024
Mentor Capital Cash Exceeds Share Price and a Second Stock Buyback is Authorized
Apr 18, 2024
WEB Aruba Signs Water-as-a-Service® BOOT Agreement with Seven Seas Water Group
Apr 18, 2024
Aqua Virginia Earns State Excellence Award for 19th Consecutive Year
Apr 18, 2024
Aqua New Jersey Celebrates Completion of Newest PFAS Treatment Facility at its Green Avenue Well Station in...
Apr 18, 2024
Black Stone Minerals, L.P. Declares Distribution for Common Units and Schedules Earnings Call to Discuss...
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events